Quizartinib, the next FLT3 inhibitor

Clin Adv Hematol Oncol. 2023 May;21(5):240-243.
No abstract available

Publication types

  • Interview

MeSH terms

  • Benzothiazoles / pharmacology
  • Humans
  • Leukemia, Myeloid, Acute*
  • Phenylurea Compounds / pharmacology
  • Phenylurea Compounds / therapeutic use
  • Protein Kinase Inhibitors* / adverse effects
  • fms-Like Tyrosine Kinase 3 / genetics

Substances

  • quizartinib
  • Protein Kinase Inhibitors
  • Benzothiazoles
  • Phenylurea Compounds
  • fms-Like Tyrosine Kinase 3
  • FLT3 protein, human